TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2011

Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer: SWOG 0012.

Georgiana K Ellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.